| Nov 8 |
Rigel Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 7 |
Rigel Pharmaceuticals (RIGL) Q3 Earnings and Revenues Top Estimates
|
| Nov 7 |
Rigel Pharmaceuticals GAAP EPS of $0.70 beats by $0.63, revenue of $55.3M beats by $13.37M
|
| Nov 7 |
Rigel: Q3 Earnings Snapshot
|
| Nov 7 |
Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Nov 6 |
Rigel Pharmaceuticals Q3 2024 Earnings Preview
|
| Nov 5 |
Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition
|
| Oct 31 |
Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update
|
| Oct 24 |
Rigel issues letter to doctors on fatal infection signal for Gavreto
|
| Oct 24 |
Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)
|
